Zomedica Corp. reiterated revenue guidance for full year 2024. For the period, the company expects revenue in the range of $31 to $35 million, an increase of approximately 40% at the high end of the range, over full year 2023 revenue of $25.2 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1828 USD | +5.24% | +30.85% | -8.69% |
05-15 | Zomedica Corp. Releases Over-The-Air Software Update Capabilities for Its Truforma(R) Platform | CI |
05-09 | Earnings Flash (ZOM) ZOMEDICA Posts Q1 Revenue $6.3M | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.69% | 170M | |
-37.02% | 919M |
- Stock Market
- Equities
- ZOM Stock
- News Zomedica Corp.
- Zomedica Corp. Reiterates Revenue Guidance for Full Year 2024